BBP vs SCHD

ABBP

BSCHD

Measures won2–4SCHD wins · of 6 · 5Y

$10,000 · 5Y$19,004BBP · SCHD $16,429

Lowest cost0.06%SCHD · $6 on $10k

Most income2.93%SCHD · $293 on $10k

Smallest drop−6.9%SCHD · worst fall in 1Y

Held in common1.7%BBP and SCHD

Virtus Biotech ETF · $135MSchwab U.S. Dividend Equity ETF · $123B

+27.5%3 years · per year$20,709 · $17,257+19.9%

+13.7%5 years · per year$19,004 · $16,429+10.4%

0.34%Expense ratio$34 · $6 on $10k · lower wins0.06%

0.00%12-mo yield$0 · $293 on $10k2.93%

−9.4%

End-of-day Nov 12, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two

5Y2 funds

#			Trend
1	ABBP	Virtus Biotech ETFRead Desk		0.34%	0.00%	−2.4%	+28.3%	+31.8%	+27.5%	+13.7%	−9.4%	$135M
2	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk		0.06%	2.93%	−0.2%	+34.2%	+36.8%	+19.9%	+10.4%	−6.9%	$122.7B

End-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

5Y2 funds

#			Trend
1	ABBP	Virtus Biotech ETFRead Desk		0.34%	0.00%	−2.4%	+28.3%	+31.8%	+27.5%	+13.7%	−9.4%	$135M
2	BSCHD	Schwab U.S. Dividend Equity ETFRead Desk		0.06%	2.93%	−0.2%	+34.2%	+36.8%	+19.9%	+10.4%	−6.9%	$122.7B

End-of-day Nov 12, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus

Cards for this view

BBP

Virtus Biotech

$19,004

SCHD

Schwab U.S. Dividend Equity

$16,429

Loading…